A study of the immunology of the chronic fatigue syndrome: Correlation of immunologic parameters to health dysfunction

被引:42
作者
Hassan, IS
Bannister, BA
Akbar, A
Weir, W
Bofill, M
机构
[1] Royal Free Hosp, Dept Infect & Trop Dis, London NW3 2QG, England
[2] Royal Free Hosp, Dept Clin Immunol, London NW3 2QG, England
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 87卷 / 01期
关键词
CFS; immunoactivation; anti-apoptosis; health dysfunction;
D O I
10.1006/clin.1997.4512
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surface and intracellular immunologic and apoptotic markers and functional lymphocyte assays after stimulation with anti-CD3/anti-CD28 antibodies or phytohemagglutinin (PHA) were studied in 44 patients fulfilling the Oxford criteria for chronic fatigue syndrome (CFS). Results were then correlated to scores for the Short Form-36 health questionnaire (SF-36), which assesses eight aspects of patient's well-being, and for the general health questionnaire (GHQ), which detects current psychiatric disorder. Patients had significantly increased mean fluorescence intensity readings of HLA-DR in CD4 and CD8 cells (P < 0.05). Expression of the costimulatory receptor CD28 in CD8 cells was significantly reduced, and the apoptosis repressor ratio of bcl-2/bax in both CD4 and CD8 was increased in patients (P < 0.05). Patients with increased HLA-DR expression had significantly lower SF-36 total scores, worse body pains, and poorer general health perception and physical functioning scores. Increased spontaneous lymphocyte proliferation was associated with poor general health perception. PHA proliferative responses were lower in patients with poor emotional and mental health scores, and the anti-CD3/anti-CD28 response was low in those with low general health perception scores. Higher spontaneous proliferation and reduced PHA responses correlated with higher GHQ scores, Similarly, GHQ scores were significantly higher, indicating worse mental health, in those with lower total SF-36 scores and worse general and mental health scores in the SF-36 questionnaire. Finally, higher expression of the costimulatory molecule CD28 correlated with higher total SF-36 scores, general health perception and social functioning scores, and with lower role limitation due to physical health. The increased expression of class II antigens and the reduced expression of the costimulatory receptor CD28, which is a marker of terminally differentiated cells, lend further support to the concept of immunoactivation of T-lymphocytes in CFS and may be consistent with the notion of a viral etiopathogenesis in the illness. We report, for the first time, increased expression of the apoptosis repressor protein bcl-2, which may contribute to enhanced survival of activated lymphocytes. Using the SF-36 health assessment questionnaire and the GHQ, we demonstrated changes in different immunological parameters, each of which correlated with particular aspects of disease symptomatology. (C) 1998 Academic Press.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 44 条
  • [1] THE SIGNIFICANCE OF LOW BCL-2 EXPRESSION BY CD45RO-T-CELLS IN NORMAL INDIVIDUALS AND PATIENTS WITH ACUTE VIRAL-INFECTIONS - THE ROLE OF APOPTOSIS IN T-CELL MEMORY
    AKBAR, AN
    BORTHWICK, N
    SALMON, M
    GOMBERT, W
    BOFILL, M
    SHAMSADEEN, N
    PILLING, D
    PETT, S
    GRUNDY, JE
    JANOSSY, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 427 - 438
  • [2] A POSSIBLE ROLE FOR BCL-2 IN REGULATING T-CELL MEMORY - A BALANCING ACT BETWEEN CELL-DEATH AND SURVIVAL
    AKBAR, AN
    SALMON, M
    SAVILL, J
    JANOSSY, G
    [J]. IMMUNOLOGY TODAY, 1993, 14 (11): : 526 - 532
  • [3] Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-x(L)) but not pro-apoptotic (bax, bcl-x(S)) gene expression
    Akbar, AN
    Borthwick, NJ
    Wickremasinghe, RG
    Panayiotidis, P
    Pilling, D
    Bofill, M
    Krajewski, S
    Reed, JC
    Salmon, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) : 294 - 299
  • [4] BOFILL M, 1995, AM J PATHOL, V146, P1542
  • [5] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)
    BOISE, LH
    MINN, AJ
    NOEL, PJ
    JUNE, CH
    ACCAVITTI, MA
    LINDSTEN, T
    THOMPSON, CB
    [J]. IMMUNITY, 1995, 3 (01) : 87 - 98
  • [6] Borthwick NJ, 1996, IMMUNOLOGY, V88, P508
  • [7] LYMPHOCYTE-ACTIVATION IN HIV-1 INFECTION .2. FUNCTIONAL DEFECTS OF CD28- T-CELLS
    BORTHWICK, NJ
    BOFILL, M
    GOMBERT, WM
    AKBAR, AN
    MEDINA, E
    SAGAWA, K
    LIPMAN, MC
    JOHNSON, MA
    JANOSSY, G
    [J]. AIDS, 1994, 8 (04) : 431 - 441
  • [8] VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE
    BRAZIER, JE
    HARPER, R
    JONES, NMB
    OCATHAIN, A
    THOMAS, KJ
    USHERWOOD, T
    WESTLAKE, L
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846): : 160 - 164
  • [9] A CHRONIC ILLNESS CHARACTERIZED BY FATIGUE, NEUROLOGIC AND IMMUNOLOGICAL DISORDERS, AND ACTIVE HUMAN HERPESVIRUS TYPE-6 INFECTION
    BUCHWALD, D
    CHENEY, PR
    PETERSON, DL
    HENRY, B
    WORMSLEY, SB
    GEIGER, A
    ABLASHI, DV
    SALAHUDDIN, SZ
    SAXINGER, C
    BIDDLE, R
    KIKINIS, R
    JOLESZ, FA
    FOLKS, T
    BALACHANDRAN, N
    PETER, JB
    GALLO, RC
    KOMAROFF, AL
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (02) : 103 - 113
  • [10] CALIGIURI M, 1987, J IMMUNOL, V139, P3306